PLI Scheme for medical devices: DoP invites applications from Category B applicants under revised guidelines

As per the revised guidelines, the list of indicative eligible products, coming under "Category B" applicants, includes Brachytherapy Systems, Radiotherapy Simulation Systems, Workstations-Radiotherapy Planning, Proton therapy systems, Cyclotrons, Needles-Anesthesia, Syringes-Anesthesia, Anesthesia Kits, Masks-Anesthesia, Biopsy Kits- Renal, Dialyser reprocessing system, Lithotripters-Extracorporeal Renal,Cochlear Implants, Spinal and neuro-surgical implants, Urogynecologic Surgical Mesh Implants, Hernia Surgical Mesh Implants, Cerebral Spinal Fluid (CSF) Shunt Systems, Implanted Pacemakers, insulin pump, implaqted neuro-stimulated device like Deep Brain Stimulators, lntraocular lenses and others.

In light of the foregoing, the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, has recently issued a notice inviting applications from eligible Category B applicants. Additionally, the notification stated that only online applications will be accepted from qualified applicants from 1.9.2022 to 31.10.2022.

"Department of Pharmaceuticals issued Notification Guidelines of the PLI Scheme for Medical Devices on 21.07.2020, which got revised on 29.10.2020, and as per this, so far, 21 applicants were selected based on the applications received under two rounds of inviting applications." the notice revealed.

"Based on the arising needs, the Department has further revised the Guidelines of the PLI Scheme for Medical Devices and issued the same on 18.08.2022," the notice added.

Pursuant to this, the department has invited applications from eligible Category B applicants for medical devices listed under four target segments in Annexure 1A of the revised scheme guidelines as given below;